REGENXBIO
Live / Registered — Registered (as of 04 Mar 2025)
What this means for you
Registered since 04 Mar 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98123485
- Registration number
- 7709745
- Mark type
- Stylized text
- Filed
- 09 Aug 2023
- Published for opposition
- 14 Jan 2025
- Registered
- 04 Mar 2025
- Attorney of record
- William R. Samuels
Goods and services
- Class 005 — Pharmaceuticals: Biotechnological platform technology, namely, biological nanoparticles, recombinant viruses, and adenoviruses for gene delivery to biological cells that includes recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, RNA interference (RNAi), and cell therapy
Owner
- RegenxBio Inc., Rockville, MD, US
- RegenxBio Inc., Rockville, MD, US
- RegenxBio Inc., Rockville, MD, US
Prosecution history
- 04 Mar 2025 — REGISTERED-PRINCIPAL REGISTER
- 04 Mar 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jan 2025 — PUBLISHED FOR OPPOSITION
- 08 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Dec 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Dec 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Dec 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Oct 2024 — ASSIGNED TO LIE
- 12 Jul 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 17 Apr 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 17 Apr 2024 — NON-FINAL ACTION E-MAILED